SEI Investments’s Crinetics Pharmaceuticals CRNX Stock Holding History

SEI Investments's CRNX Position: Q2 2026 in Review

SEI Investments increased its Crinetics Pharmaceuticals (CRNX) stake by 13% in Q2 2026, buying an estimated $344K and bringing the position to 83,225 shares worth $3.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1729.

SEI Investments first reported a position in CRNX in Q3 2023 and has held it in 12 quarters since. The position peaked at $3.35M in Q4 2025. 267 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

• SEI Investments held 83,225 shares of Crinetics Pharmaceuticals worth $3.11M as of Q2 2026.
• SEI Investments bought 9,264 Crinetics Pharmaceuticals shares in Q2 2026, an estimated $344K.
• Crinetics Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #1729 holding.
• SEI Investments first reported a position in Crinetics Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
• SEI Investments's Crinetics Pharmaceuticals position peaked at $3.35M in Q4 2025.
• 267 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.